PT  - JOURNAL ARTICLE
AU  - Grubaugh, Nathan D.
AU  - Torres-Hernández, Daniela
AU  - Murillo-Ortiz, Mónica A.
AU  - Dávalos, Diana M.
AU  - Hurtado, Isabel C.
AU  - Breban, Mallery I.
AU  - Bourgikos, Ellie
AU  - Hill, Verity
AU  - López, Eduardo
TI  - 2023-24 dengue outbreak in Valle del Cauca, Colombia caused by multiple virus serotypes and lineages
AID  - 10.1101/2024.07.16.24310413
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.16.24310413
4099  - http://medrxiv.org/content/early/2024/07/16/2024.07.16.24310413.short
4100  - http://medrxiv.org/content/early/2024/07/16/2024.07.16.24310413.full
AB  - Global dengue cases rapidly rose to record levels in 2023-24. We investigated this trend in Valle del Cauca, Colombia to determine if specific dengue virus serotypes or lineages were responsible for the large outbreak. We detected all four serotypes and multiple lineages, suggesting that other factors, such as climatic conditions, are likely responsible.Competing Interest StatementNDG is a paid consultant for BioNTech.Funding StatementThis publication was made possible by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under Award Number DP2AI176740 (NDG) and an NIH Shared Equipment grant 1S10OD028669-01 award to the Yale Center for Genome Analysis. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our study was approved by the Research Ethics Committee at HUV and Yale University Human Research Protection Program (Protocol ID: 2000033281) and all participants signed an informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesOur sequencing data can be found at NCBI BioProject PRJNA1132139 and the GenBank accession numbers are listed in Appendix Table. Our alignments, trees, and Nextstrain outputs are available at: github.com/grubaughlab/DENV-genomics/tree/master/paper_2024-CO. https://www.github.com/grubaughlab/DENV-genomics/tree/master/paper_2024-CO